Evidence map›Paper›PMID 36275655›Full record

ArticleFrontiers in immunology2022

Comparison of blood and lymph node cells after intramuscular injection with HIV envelope immunogens.

Suzanne Day, Charandeep Kaur, Hannah M Cheeseman, Emily de Groot, Leon R McFarlane, Maniola Tanaka, Sofia Coelho, Tom Cole, Nana-Marie Lemm, Adrian Lim and 4 more

Registry-linked trialOpen access · goldAbstract readClinical Study
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04046978 (An Experimental Medicine Study Modelling the Interaction Between Rationally-designed Synthetic Model Viral Protein Immunogens and the Breadth of the Induced B and T Cell Repertoires.), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04046978 nawithdrawnnot on this map

An Experimental Medicine Study Modelling the Interaction Between Rationally-designed Synthetic Model Viral Protein Immunogens and the Breadth of the Induced B and T Cell Repertoires.

TypeinterventionalSponsorImperial College LondonRan2019 to 2022Enrolled0ConditionsVirus DiseasesArmsConM SOSIP 50 ug and ConS UFO 50 ug, Mos3.1 100 ug, Mos3.2 100 ug, Mos3.3 100 ug, Mos3.1 33 ug, Mos3.2 33 ug and Mos3.3 33 ug
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Suzanne DayDepartment of Infectious Disease, Imperial College London, London, United Kingdom.
Charandeep KaurDepartment of Infectious Disease, Imperial College London, London, United Kingdom.
Hannah M CheesemanDepartment of Infectious Disease, Imperial College London, London, United Kingdom.
Emily de GrootDepartment of Infectious Disease, Imperial College London, London, United Kingdom.
Leon R McFarlaneDepartment of Infectious Disease, Imperial College London, London, United Kingdom.
Maniola TanakaNational Institute for Health and Care Research (NIHR) Imperial Clinical Research Facility, Imperial College Healthcare National Health Service (NHS) Trust, London, United Kingdom.
Sofia CoelhoNational Institute for Health and Care Research (NIHR) Imperial Clinical Research Facility, Imperial College Healthcare National Health Service (NHS) Trust, London, United Kingdom.
Tom ColeNational Institute for Health and Care Research (NIHR) Imperial Clinical Research Facility, Imperial College Healthcare National Health Service (NHS) Trust, London, United Kingdom.
Nana-Marie LemmDepartment of Infectious Disease, Imperial College London, London, United Kingdom.
Adrian LimDepartment of Breast Radiology, Charing Cross Hospital, Imperial College Healthcare National Health Service (NHS) Trust, London, United Kingdom.
Rogier W SandersMedical Microbiology and Infection Prevention, Amsterdam University Medical Centers (UMC), University of Amsterdam, Amsterdam, Netherlands.
Becca AsquithDepartment of Infectious Disease, Imperial College London, London, United Kingdom.
Robin J ShattockDepartment of Infectious Disease, Imperial College London, London, United Kingdom.
Katrina M PollockDepartment of Infectious Disease, Imperial College London, London, United Kingdom.
Imperial College London · GBImperial College Healthcare NHS Trust · GBNational Health Service · GBAmsterdam University Medical Centers · NL

Funding

Bloodwise 15012Department of HealthMedical Research Council G1001052Medical Research Council MR/W024977/1Wellcome Trust
6 · The paper itself

Abstract

Background: Harnessing CD4+ T cell help in the lymph nodes through rational antigen design could enhance formation of broadly neutralizing antibodies (bNAbs) during experimental HIV immunization. This process has remained hidden due to difficulty with direct study, with clinical studies instead focusing on responses in the blood as a proxy for the secondary lymphoid tissue. Methods: To address this, lymph node cells (LNC) were collected using ultrasound guided fine needle aspiration of axillary lymph nodes from 11 HIV negative participants in an experimental HIV immunogen study (European AIDS Vaccine Initiative EAVI2020_01 study, NCT04046978). Cells from lymph node and blood (PBMC), were collected after intramuscular injection with HIV Env Mosaic immunogens based on HIV Envelope glycoprotein and combined with a liposomal toll-like receptor-4 adjuvant; monophosphoryl lipid A. Simultaneously sampled cells from both blood and lymph node in the same donors were compared for phenotype, function, and antigen-specificity. Results: Unsupervised cluster analysis revealed tissue-specific differences in abundance, distribution, and functional response of LNC compared with PBMC. Monocytes were virtually absent from LNC, which were significantly enriched for CD4+ T cells compared with CD8+ T cells. T follicular helper cells with germinal center features were enriched in LNC, which contained specific CD4+ and CD8+ T cell subsets including CD4+ T cells that responded after a single injection with HIV Env Mosaic immunogens combined with adjuvant. Tissue-specific differences in response to an MHC-II dependent superantigen, staphylococcal enterotoxin B, indicated divergence in antigen presentation function between blood and lymph node. Conclusions: LNC are phenotypically and functionally distinct from PBMC, suggesting that whole blood is only a limited proxy of the T cell lymphatic response to immunization. HIV-specific CD4+ T cells in the lymph node are rapidly inducible upon experimental injection with HIV immunogens. Monitoring evolution of CD4+ T cell memory in LNC with repeated experimental HIV immunization could indicate the strategies most likely to be successful in inducing HIV-specific bNAbs.

Indexed as

AIDS VaccinesHIV InfectionsAntibodies, NeutralizingBroadly Neutralizing AntibodiesGlycoproteinsHIV AntigensHumansInjections, IntramuscularLeukocytes, MononuclearLymph NodesSuperantigensToll-Like ReceptorsAIDS VaccinesAntibodies, NeutralizingBroadly Neutralizing AntibodiesGlycoproteinsHIV AntigensSuperantigensToll-Like ReceptorsCD4+ T cellenvelopeHIVHIV envelopelymph node cellsT cellT follicular helper cellvaccine

Identifiers

PMID36275655
PMCPMC9579690
OpenAlexW4301595283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.